However, most CD133+ cells had high tumorigenicity and invasion characteristics (18) and therefore, CD133+ expressing glioblastoma cells were considered as the observation subject with the aim of further developing the scope and depth of understanding of glioma stem cell research. Here, PROM1 is linked to central nervous system cancer.